Inspirna (formerly Rgenix)Verified
Biotechnology company developing drugs for the treatment of cancer
$200—300m (Dealroom.co estimates Jul 2022.)
New York City New York (HQ)
Not yet verified
Recent News about Inspirna (formerly Rgenix)Edit
Tech stackLearn more about the technologies and tools that this company uses.